BHVN Q4 2023 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$948,000

Operating Income

-$154M

Net Income

-$145M

EPS (Diluted)

$-1.81

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$115M

Free Cash Flow

-$115M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$513M

Total Liabilities

$85M

Stockholders' Equity

$428M

Cash & Equivalents

$248M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$948,000	$0	—
Operating Income	-$154M	-$213M	+28.0%
Net Income	-$145M	-$201M	+28.0%